TXNDC5 and breast carcinoma: Using this antagonist, ITGB1 and TXNDC5 proteins were downregulated, and similar results were observed for the induction of NR4A1-responsive genes CDKN1A, SERPINB5 and GADD45α in breast cancer MDA-MB-231 and SKBR3 cells.